Form 4 for CODX Co-Diagnostics, Inc.
Accepted 2025-05-27 00:00:00 ET · period of report 2025-05-23 · accession 0001562180-25-004198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-27 | 2025-05-23 | CODX | Abbott Richard David | Pres | D - Sale to Iss | $0.24 | -7,180 | 26.7K | -21% | -$1,723 |
| D | 2025-05-27 | 2025-05-23 | CODX | Abbott Richard David | Pres | A - Grant | $0.00 | +20.0K | 33.9K | +144% | $0 |
| D | 2025-05-27 | 2025-05-23 | CODX | Abbott Richard David | Pres | M - OptEx | $0.00 | -20.0K | 130.4K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-23 | D | D | 7,180 | $0.24 | 26,735 | D | — | — | (F2) Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
| 2 | Common | Common Stock | 2025-05-23 | A | A | 20,000 | $0.00 | 33,915 | D | — | — | (F1) Included in 120,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024. |
| 3 | Derivative | Restricted Stock Unit | 2025-05-23 | M | D | 20,000 | $0.00 | 130,438 | D | $0.00 · — to — | 150,438 Common Stock | (F1) Included in 120,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024. |